The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Biomimetic Nanoerythrosome‐Coated Aptamer–DNA Tetrahedron/Maytansine Conjugates: pH‐Responsive and Targeted Cytotoxicity for HER2‐Positive Breast Cancer
Abstract
DNA materials have emerged as potential nanocarriers for targeted cancer therapy to precisely deliver cargos with specific purposes. The short half‐life and low bioavailability of DNA materials due to their interception by the reticuloendothelial system and blood clearance further limit their clinical translation. This study employs an HER2‐targeted DNA‐aptamer‐modified DNA tetrahedron (HApt‐tFNA) as a drug delivery system, and combines maytansine (DM1) to develop the HApt‐DNA tetrahedron/DM1 conjugate (HApt‐tFNA@DM1, HTD, HApDC) for targeted therapy of HER2‐positive cancer. To optimize the pharmacokinetics and tumor‐aggregation of HTD, a biomimetic camouflage is applied to embed HTD. The biomimetic camouflage is constructed by merging the erythrocyte membrane with pH‐responsive functionalized synthetic liposomes, thus with excellent performance of drug delivery and tumor‐stimulated drug release. The hybrid erythrosome‐based nanoparticles show better inhibition of HER2‐positive cancer than other drug formulations and exhibit superior biosafety. With the strengths of precise delivery, increased drug loading, sensitive tumor probing, and prolonged circulation time, the HApDC represents a promising nanomedicine to treat HER2‐positive tumors. Notably, this study developsa dual‐targeting nanoparticle by combining pH‐sensitive camouflage and HApDC, initiating an important step toward the development and application of DNA‐based medicine and biomimetic cell membrane materials in cancer treatment and other potential biological applications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bang, Y.-J., Van Cutsem, E., Feyereislova, A., Chung, H. C., Shen, L., Sawaki, A., Lordick, F., Ohtsu, A., Omuro, Y., Satoh, T., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61121-x · Cited by 7,302
Organization of 'nanocrystal molecules' using DNA
Alivisatos, A. P., Johnsson, K. P., Peng, X., Wilson, T. E., Loweth, C. J., Bruchez, M. P., & Schultz, P. G. (1996) · Nature · doi:10.1038/382609a0 · Cited by 2,962
Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer
von Minckwitz, G., Huang, C.-S., Mano, M. S., Loibl, S., Mamounas, E. P., Untch, M., Wolmark, N., Rastogi, P., Schneeweiss, A., Redondo, A., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1814017 · Cited by 2,625
Cell Membrane Coating Nanotechnology
Fang, R. H., Kroll, A. V., Gao, W., & Zhang, L. (2018) · Advanced Materials · doi:10.1002/adma.201706759 · Cited by 1,885
Targeting HER2-Positive Breast Cancer with Trastuzumab-DM1, an Antibody–Cytotoxic Drug Conjugate
Lewis Phillips, G. D., Li, G., Dugger, D. L., Crocker, L. M., Parsons, K. L., Mai, E., Blättler, W. A., Lambert, J. M., Chari, R. V. J., Lutz, R. J., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1776 · Cited by 1,676
Self-assembly of a nanoscale DNA box with a controllable lid
Andersen, E. S., Dong, M., Nielsen, M. M., Jahn, K., Subramani, R., Mamdouh, W., Golas, M. M., Sander, B., Stark, H., Oliveira, C. L. P., et al. (2009) · Nature · doi:10.1038/nature07971 · Cited by 1,627
Cancer Cell Membrane-Coated Nanoparticles for Anticancer Vaccination and Drug Delivery
Fang, R. H., Hu, C.-M. J., Luk, B. T., Gao, W., Copp, J. A., Tai, Y., O’Connor, D. E., & Zhang, L. (2014) · Nano Letters · doi:10.1021/nl500618u · Cited by 1,501
Synthesis from DNA of a molecule with the connectivity of a cube
Chen, J., & Seeman, N. C. (1991) · Nature · doi:10.1038/350631a0 · Cited by 1,369
Loibl, S., & Gianni, L. (2017) · The Lancet · doi:10.1016/s0140-6736(16)32417-5 · Cited by 1,116
Assembling Materials with DNA as the Guide
Aldaye, F. A., Palmer, A. L., & Sleiman, H. F. (2008) · Science · doi:10.1126/science.1154533 · Cited by 976
Antibody–drug conjugates for cancer
Chau, C. H., Steeg, P. S., & Figg, W. D. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31774-x · Cited by 816
Biology of HER2 and Its Importance in Breast Cancer
Yarden, Y. (2001) · Oncology · doi:10.1159/000055396 · Cited by 737
DNA Functional Materials Assembled from Branched DNA: Design, Synthesis, and Applications
Dong, Y., Yao, C., Zhu, Y., Yang, L., Luo, D., & Yang, D. (2020) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00294 · Cited by 533
Aptamer-based targeted therapy
Zhu, G., & Chen, X. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.08.005 · Cited by 522
Self-citationCD47 Protects Synapses from Excess Microglia-Mediated Pruning during Development
Lehrman, E. K., Wilton, D. K., Litvina, E. Y., Welsh, C. A., Chang, S. T., Frouin, A., Walker, A. J., Heller, M. D., Umemori, H., Chen, C., et al. (2018) · Neuron · doi:10.1016/j.neuron.2018.09.017 · Cited by 468
Zhang, T., Tian, T., Zhou, R., Li, S., Ma, W., Zhang, Y., Liu, N., Shi, S., Li, Q., Xie, X., et al. (2020) · Nature Protocols · doi:10.1038/s41596-020-0355-z · Cited by 453
Self-citationAptamers Chemistry: Chemical Modifications and Conjugation Strategies
Odeh, F., Nsairat, H., Alshaer, W., Ismail, M. A., Esawi, E., Qaqish, B., Bawab, A. A., & Ismail, S. I. (2019) · Molecules · doi:10.3390/molecules25010003 · Cited by 415
Chen, H.-Y., Deng, J., Wang, Y., Wu, C.-Q., Li, X., & Dai, H.-W. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.05.028 · Cited by 402
Li, J. Y., Perry, S. R., Muniz-Medina, V., Wang, X., Wetzel, L. K., Rebelatto, M. C., Hinrichs, M. J. M., Bezabeh, B. Z., Fleming, R. L., Dimasi, N., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2015.12.008 · Cited by 397
Reyes-Reyes, E. M., Teng, Y., & Bates, P. J. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0920 · Cited by 383
Functionalizing Framework Nucleic‐Acid‐Based Nanostructures for Biomedical Application
Zhang, T., Tian, T., & Lin, Y. (2022) · Advanced Materials · doi:10.1002/adma.202107820 · Cited by 368
Self-citationRed blood cell–derived nanoerythrosome for antigen delivery with enhanced cancer immunotherapy
Han, X., Shen, S., Fan, Q., Chen, G., Archibong, E., Dotti, G., Liu, Z., Gu, Z., & Wang, C. (2019) · Science Advances · doi:10.1126/sciadv.aaw6870 · Cited by 349
Self-citationThe biological applications of DNA nanomaterials: current challenges and future directions
Ma, W., Zhan, Y., Zhang, Y., Mao, C., Xie, X., & Lin, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00727-9 · Cited by 331
Self-citationTransformable peptide nanoparticles arrest HER2 signalling and cause cancer cell death in vivo
Zhang, L., Jing, D., Jiang, N., Rojalin, T., Baehr, C. M., Zhang, D., Xiao, W., Wu, Y., Cong, Z., Li, J. J., et al. (2020) · Nature Nanotechnology · doi:10.1038/s41565-019-0626-4 · Cited by 270
Natural killer cell membrane infused biomimetic liposomes for targeted tumor therapy
Pitchaimani, A., Nguyen, T. D. T., & Aryal, S. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.01.018 · Cited by 249
Engineering Biomimetic Platesomes for pH‐Responsive Drug Delivery and Enhanced Antitumor Activity
Liu, G., Zhao, X., Zhang, Y., Xu, J., Xu, J., Li, Y., Min, H., Shi, J., Zhao, Y., Wei, J., et al. (2019) · Advanced Materials · doi:10.1002/adma.201900795 · Cited by 233
An Intelligent DNA Nanorobot with in Vitro Enhanced Protein Lysosomal Degradation of HER2
Ma, W., Zhan, Y., Zhang, Y., Shao, X., Xie, X., Mao, C., Cui, W., Li, Q., Shi, J., Li, J., et al. (2019) · Nano Letters · doi:10.1021/acs.nanolett.9b01320 · Cited by 207
Self-citationG-Quadruplex-Forming Aptamers—Characteristics, Applications, and Perspectives
Roxo, C., Kotkowiak, W., & Pasternak, A. (2019) · Molecules · doi:10.3390/molecules24203781 · Cited by 207
Oroudjev, E., Lopus, M., Wilson, L., Audette, C., Provenzano, C., Erickson, H., Kovtun, Y., Chari, R., & Jordan, M. A. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0645 · Cited by 164
Overcoming drug-resistant lung cancer by paclitaxel loaded tetrahedral DNA nanostructures
Xie, X., Shao, X., Ma, W., Zhao, D., Shi, S., Li, Q., & Lin, Y. (2018) · Nanoscale · doi:10.1039/c7nr09692e · Cited by 161
Self-citationDual blockade of CD47 and HER2 eliminates radioresistant breast cancer cells
Candas, D., Xie, B., Huang, J., Fan, M., Wang, A., Menaa, C., Zhang, Y., Zhang, L., Jing, D., Azghadi, S. F., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18245-7 · Cited by 157
Liao, Z., Chuang, E., Lin, C.-C., Ho, Y., Lin, K., Cheng, P., Chen, K., Wei, H.-J., & Sung, H. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.01.032 · Cited by 145
Zhang, Y., Leonard, M., Shu, Y., Yang, Y., Shu, D., Guo, P., & Zhang, X. (2016) · ACS Nano · doi:10.1021/acsnano.6b05910 · Cited by 138
Self-citationBioswitchable Delivery of microRNA by Framework Nucleic Acids: Application to Bone Regeneration
Li, S., Liu, Y., Tian, T., Zhang, T., Lin, S., Zhou, M., Zhang, X., Lin, Y., & Cai, X. (2021) · Small · doi:10.1002/smll.202104359 · Cited by 132
Self-citationMoody, P. R., Sayers, E. J., Magnusson, J. P., Alexander, C., Borri, P., Watson, P., & Jones, A. T. (2015) · Molecular Therapy · doi:10.1038/mt.2015.178 · Cited by 124
A basic insight into aptamer-drug conjugates (ApDCs)
Xuan, W., Peng, Y., Deng, Z., Peng, T., Kuai, H., Li, Y., He, J., Jin, C. Y., Liu, Y., Wang, R., et al. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.08.021 · Cited by 120
Yu, X., Ghamande, S. A., Liu, H., Xue, L., Zhao, S., Tan, W., Zhao, L., Tang, S.-C., Wu, D., Körkaya, H., et al. (2017) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2017.12.015 · Cited by 99
Nanoparticles Encapsulating Nitrosylated Maytansine To Enhance Radiation Therapy
Gao, S. Q., Zhang, W., Wang, R., Hopkins, S. P., Spagnoli, J. C., Racin, M., Bai, L., Li, L., Jiang, W., Yang, X., et al. (2020) · ACS Nano · doi:10.1021/acsnano.9b05976 · Cited by 97
Li, Y., Gao, S., Shi, S., Xiao, D., Peng, S., Gao, Y., Zhu, Y. J., & Lin, Y. (2021) · Nano-Micro Letters · doi:10.1007/s40820-021-00614-6 · Cited by 85
Self-citationTian, T., Zhang, T., Zhou, T., Lin, S., Shi, S., & Lin, Y. (2017) · Nanoscale · doi:10.1039/c7nr07130b · Cited by 81
Self-citationEffects of tetrahedral DNA nanostructures on autophagy in chondrocytes
Shi, S., Lin, S., Li, Y., Zhang, T., Shao, X., Tian, T., Zhou, T., Li, Q., & Lin, Y. (2018) · Chemical Communications · doi:10.1039/c7cc09397g · Cited by 78
Self-citationMechanism of microtubule stabilization by taccalonolide AJ
Wang, Y., Yu, Y., Li, G., Li, S., Wu, C., Gigant, B., Qin, W., Chen, H., Wu, Y., Chen, Q., et al. (2017) · Nature Communications · doi:10.1038/ncomms15787 · Cited by 76
Yang, J., Yu, Y., Li, Y., Yan, W., Ye, H., Niu, L., Tang, M., Wang, Z., Yang, Z., Pei, H., et al. (2021) · Science Advances · doi:10.1126/sciadv.abg4168 · Cited by 71
Menchon, G., Prota, A. E., Lucena‐Agell, D., Bucher, P., Jansen, R., Irschik, H., Müller, R., Paterson, I., Díaz, J. F., Altmann, K., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04535-8 · Cited by 65
Tetrahedral Framework Nucleic Acids Induce Immune Tolerance and Prevent the Onset of Type 1 Diabetes
Gao, S., Li, Y., Xiao, D., Zhou, M., Cai, X., & Lin, Y. (2021) · Nano Letters · doi:10.1021/acs.nanolett.1c01131 · Cited by 60
Self-citationCoating and Stabilization of Liposomes by Clathrin-Inspired DNA Self-Assembly
Baumann, K. N., Piantanida, L., García‐Nafría, J., Sobota, D., Voïtchovsky, K., Knowles, T. P. J., & Hernández‐Ainsa, S. (2020) · ACS Nano · doi:10.1021/acsnano.9b09453 · Cited by 55
Ge, Y., Tian, T., Shao, X., Lin, S., Zhang, T., Lin, Y., & Cai, X. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b09243 · Cited by 50
Self-citationCong, X., Tian, H., Liu, S., Mao, K., Chen, H., Xin, Y., Liu, F., Wang, X., Meng, X., Zhu, G., et al. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c08112 · Cited by 47
Self-citationAn intelligent cell-selective polymersome-DM1 nanotoxin toward triple negative breast cancer
Zhang, Y., Yue, S., Haag, R., Sun, H., & Zhong, Z. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.11.014 · Cited by 32
Targeting the autophagy promoted antitumor effect of T-DM1 on HER2-positive gastric cancer
Zhang, J., Fan, J., Zeng, X. L., Nie, M., Chen, W., Wang, Y., Luan, J., Zhu, Z., Chang, X., Ju, D., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-020-03349-1 · Cited by 29
Construction of Bispecific Aptamer–Drug Conjugate by a Hybrid Chemical and Biological Approach
Sun, Y., Gao, F., Cai, Y., Li, Y., Jin, C. Y., Xie, S., Lv, C., Ding, D., Han, D., Li, J., et al. (2020) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.0c00071 · Cited by 22
Tan, Y. H., Peng, Y., Ai, L., Li, Y., Qu, Y.-X., Wang, D., Su, Y., Deng, T., Fu, T., Zhao, Z., et al. (2020) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.0c00250 · Cited by 13
Aptamer Targeting the ERBB2 Receptor Tyrosine Kinase for Applications in Tumor Therapy
Mahlknecht, G., Sela, M., & Yarden, Y. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2727-2_1 · Cited by 11
Cited by
Nanoparticles in tumor microenvironment remodeling and cancer immunotherapy
Lu, Q., Kou, D., Lou, S., Ashrafizadeh, M., Aref, A. R., Canadas, I., Tian, Y., Niu, X., Wang, Y., Torabian, P., et al. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01535-8 · Cited by 373
Metadata
- Authors
- Ma, W., Yang, Y., Zhu, J., Jia, W., Zhang, T., Liu, Z., Chen, X., & Lin, Y.
- Venue
- Advanced Materials
- Publisher
- Wiley
- Published
- 2022-02-17
- Volume
- 34
- Issue
- 46
- Pages
- e2109609-e2109609
- ISSN
- 0935-9648 (ISSN-L)
- 1521-4095
- OpenAlex
- W4207043059
- Cited by
- 300
- References
- 53
- FWCI
- 14.31
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.